HCC
NBSE

Hirtle Callaghan & Co’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

Hirtle Callaghan & Co’s Portfolio NBSE Stock Details NBSE Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-6
Closed -$18K – 382
2014
Q4 		$18K Hold
6
– – ﹤0.01% 390
2014
Q3 		$16K Hold
6
– – ﹤0.01% 434
2014
Q2 		$21K Hold
6
– – ﹤0.01% 458
2014
Q1 		$32K Buy
+6
New +$32K 0.01% 403